Start here if you're new
what it is
System1 buys internet traffic, sends it to its own sites, and tries to make more money from each click than it spent.
how it gets paid
Last year Inc. made $266M in revenue. Search and privacy was the main engine at $106M, or 40% of sales.
why growth slowed
Revenue fell 22.6% last year. TTM revenue is still down 22.6%. That tells you the turnaround case needs more than one loud quarter.
what just happened
The quarter printed $214M in revenue, but the bigger truth is that System1 still lost money and trailing revenue is still down vs. prior year.
At a glance
C balance sheet — red flag territory — real financial stress
-$10.70 fy2024 eps est
$344M fy2024 rev est
23.3% operating margin
1.8 beta
xvary composite: 25/100 — weak
What they do
System1 buys internet traffic, sends it to its own sites, and tries to make more money from each click than it spent.
System1 owns digital properties people still use, including Startpage, MapQuest, HowStuffWorks, and CouponFollow. That matters because owned traffic means you are not paying a middleman for every visitor. With 300 employees supporting a $266M trailing revenue base from SEC data, the platform has enough scale to test, route, and monetize user intent across multiple brands.
How they make money
$266M
annual revenue · their business grew -22.6% last year
Search and privacy
$106M
Shopping and coupons
$48M
Navigation and travel
$32M
Content and publishing
$40M
Revenue-sharing and services
$40M
The products that matter
ad matching and monetization engine
RAMP platform
~$186M · about 70% of revenue
this is still the center of gravity, and it fell 31% last year. when your largest revenue engine is shrinking that fast, the rest of the business stops being a growth story and starts being damage control.
core but under pressure
owned consumer sites and traffic brands
Consumer Products
~$80M · about 30% of revenue
this segment grew 8% while the total business fell 23%. that's the one visible pocket of progress. if you want to believe the turnaround, this is where you start looking.
the only growth pocket
what the mix tells you
Revenue mix
70% shrinking · 30% growing
this is less a product card than a reality check. the math says the healthier slice is not yet big enough to carry the company. you need that ratio to improve, not just the headlines.
mix problem
Key numbers
$238M
long-term debt
This debt stack is about 12 times the company's roughly $20M market cap, which tells you who really sits first in line.
23.3%
operating margin
Operating margin → profit after running the business → so what: the core model is still losing money on every revenue dollar.
$266M
ttm revenue
That is the current sales base from SEC data, down 22.6% vs. prior year, so you are underwriting a shrinking top line.
1.8
beta
Beta → how violently a stock tends to move versus the market → so what: SST is built for turbulence, not sleep.
Financial health
C
strength
- balance sheet grade C — very weak — significant financial distress
- risk rank 5 — safer than 5% of stocks
- price stability 5 / 100
- long-term debt $238M (92% of capital)
C — balance sheet grade and long-term debt are flagged. this stock carries more risk than average.
Total return vs. market
Return history isn't available for SST right now.
source: institutional data · return history unavailable
What just happened
missed estimates
The quarter printed $214M in revenue, but the bigger truth is that System1 still lost money and trailing revenue is still down vs. prior year.
Latest-quarter revenue was $214M, up 248% vs. prior year, while EPS was -$6.67, down 190% vs. prior year. Contrast frame: one quarter looked huge, but SEC data still shows trailing revenue at $266M, down 22.6% vs. prior year.
$214M
revenue
$6.67
eps
23.3%
operating margin
the number that mattered
TTM revenue is still down 22.6%. That tells you the turnaround case needs more than one loud quarter.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
this is not generic small-cap risk. it is specific SST risk: a shrinking core business, exchange pressure, and a 2027 debt maturity that sits on top of a $20M equity stub.
high
going-concern warning
management has already flagged substantial doubt about the company's ability to continue as a going concern.
when the company itself says survival is a live question, equity holders are the residual claim. that is finance-speak for last in line.
high
$238M due in 2027
long-term debt is $238M, equal to 92% of capital and roughly 12 times the current market cap.
refinancing risk dominates the equity case. if creditors are not comfortable, the stock's upside math stops mattering.
med
core revenue keeps shrinking
total revenue fell 23% to $266M, and Platform Revenue — still about 70% of sales — dropped 31%.
a turnaround gets much harder when the largest business line keeps moving the wrong way. the smaller growth bucket has to run faster just to keep up.
med
profit proxy is collapsing
adjusted EBITDA fell 54% to $8.2M while net loss reached $17.8M.
less operating cushion means less room for error on debt, listing status, or another soft quarter. turnarounds need time. weak EBITDA buys less of it.
a $20M market cap sitting under $238M of debt only works if revenue stabilizes and a refinancing path gets credible fast.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
whether Product Revenue stays positive
Product Revenue grew 8% while the total business fell 23%. if that growth fades, the one visible offset inside the model gets weaker immediately.
risk
any refinancing update on the 2027 debt
$238M due in 2027 is the number sitting above everything else. no credible debt plan means the equity still trades like a speculation, not a turnaround.
calendar
2026 ICR conference commentary
listen for management on liquidity, exchange compliance, and whether demand in the platform business looks any better than it did in the last report.
trend
whether Platform Revenue decline starts to moderate
31% declines do not leave much room for narrative optimism. if that number does not improve meaningfully, the rest of the turnaround case stays trapped under it.
Analyst rankings
street coverage
thin
in human-speak, there are estimates on the page, but not enough ranking depth here to outsource the thesis to Wall Street.
earnings view
-$10.70
fy2024 EPS estimate still points to losses. translation: analysts are not modeling a clean near-term escape.
revenue view
$344M
the revenue estimate implies a rebound from $266M last year. that's the expectation. it is not the evidence.
source: institutional data
Institutional activity
institutional ownership data for SST is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$4
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive